Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034065 (
pulmonary embolism
)
14,979
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bothrops lanceolatus
snake venom causes systemic thrombotic syndrome but also local inflammation involving extensive oedema, pain, and haemorrhage. Systemic thrombotic syndrome may lead to fatal
pulmonary embolism
and myocardial and cerebral infarction. Here, we investigated the ability of
B. lanceolatus
venom to activate the Complement system (C) in order to improve the understanding of venom-induced local inflammation. Data presented show that
B. lanceolatus
venom is able to activate all C-pathways. In human serum, the venom strongly induced the generation of anaphylatoxins, such as C5a and C4a, and the Terminal Complement complex. The venom also induced cleavage of purified human components C3, C4, and C5, with the production of biologically active C5a. Furthermore, the venom enzymatically inactivated the soluble C-regulator and the C1-inhibitor (C1-INH), and significantly increased the expression of bound C-regulators, such as
MCP
and CD59, on the endothelial cell membrane. Our observations that
B. lanceolatus
venom activates the three Complement activation pathways, resulting in anaphylatoxins generation, may suggest that this could play an important role in local inflammatory reaction and systemic thrombosis caused by the venom. Inactivation of C1-INH, which is also an important inhibitor of several coagulation proteins, may also contribute to inflammation and thrombosis. Thus, further
in vivo
studies may support the idea that therapeutic management of systemic
B. lanceolatus
envenomation could include the use of Complement inhibitors as adjunct therapy.
...
PMID:Venom from
Bothrops lanceolatus
, a Snake Species Native to Martinique, Potently Activates the Complement System. 3011 49